Sir,We enjoy reading the recent report on ‘Wilms’ tumour and chemotherapeutic access’.[1] Anyanwa et al. reported that ‘an institutionalised approach can help to improve access to anti-cancer drugs, reduce the rate of loss to follow-up and thus improve outcome’.[1] In fact, the problem of anticancer drug access can be seen in many developing countries. In a previous report by Uba and Chirdan, ‘poor availability of cytotoxic drugs’ is an important factor contributing to the poor outcome of disease in Nigeria.[2] It is suggested that pre-operative combined chemotherapy is required for the better operative curative outcome of paediatric cases of Wilms’ tumours.[3] To manage the high cost of chemotherapy, some new studies show that metronomic chemotherapy can be the hope for the management of the problem.[4]